$ALMU
Aeluma, Inc. Stock $almu

$almu Overview Financials Valuation SEC Filings Company Website

2022 Q3 Form 10-K Financial Statement

#000121390022059543 Filed on September 28, 2022

Income Statement

Concept	2022 Q3	2022
Revenue
YoY Change
Cost Of Revenue
YoY Change
Gross Profit	$0.00	$0.00
YoY Change
Gross Profit Margin
Selling, General & Admin		$2.670M
YoY Change
% of Gross Profit
Research & Development	$629.5K	$1.064M
YoY Change	539.4%
% of Gross Profit
Depreciation & Amortization		$98.99K
YoY Change
% of Gross Profit
Operating Expenses	$1.567M	$3.734M
YoY Change	125.5%	1359.26%
Operating Profit	-$1.567M	-$3.734M
YoY Change	125.5%
Interest Expense		$2.100K
YoY Change		-170.0%
% of Operating Profit
Other Income/Expense, Net	$36.65K	$281.8K
YoY Change	-59.79%	563.89%
Pretax Income	-$1.530M	-$3.452M
YoY Change	153.46%	1495.05%
Income Tax
% Of Pretax Income
Net Earnings	-$1.530M	-$3.452M
YoY Change	153.46%	1489.18%
Net Earnings / Revenue
Basic Earnings Per Share	-$0.14	-$0.32
Diluted Earnings Per Share	-$0.14	-$0.32
COMMON SHARES
Basic Shares Outstanding	10.65M shares	10.65M shares
Diluted Shares Outstanding	10.65M shares	10.65M shares

Balance Sheet

Concept	2022 Q3	2022 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents	$2.371M	$3.741M
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets	$3.383M	$4.431M
YoY Change		-40.7%
LONG-TERM ASSETS
Property, Plant & Equipment		$987.0K
YoY Change
Goodwill
YoY Change
Intangibles	$12.08K	$12.83K
YoY Change		-13.48%
Long-Term Investments
YoY Change
Other Assets	$13.01K	$13.01K
YoY Change		-80.0%
Total Long-Term Assets	$1.471M	$1.500M
YoY Change		-6.87%
TOTAL ASSETS
Total Short-Term Assets	$3.383M	$4.431M
Total Long-Term Assets	$1.471M	$1.500M
Total Assets	$4.854M	$5.931M
YoY Change		-34.7%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable		$114.1K
YoY Change
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$795.7K	$372.4K
YoY Change		29.72%
LONG-TERM LIABILITIES
Long-Term Debt
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities	$795.7K	$372.4K
Total Long-Term Liabilities
Total Liabilities	$1.214M	$831.1K
YoY Change		-7.4%
SHAREHOLDERS EQUITY
Retained Earnings	-$5.213M	-$3.682M
YoY Change		1494.69%
Common Stock	$1.066K	$1.066K
YoY Change		1.14%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$3.640M	$5.100M
YoY Change
Total Liabilities & Shareholders Equity	$4.854M	$5.931M
YoY Change		-34.7%

Cashflow Statement

Concept	2022 Q3	2022
OPERATING ACTIVITIES
Net Income	-$1.530M	-$3.452M
YoY Change	153.46%	1489.18%
Depreciation, Depletion And Amortization		$98.99K
YoY Change
Cash From Operating Activities	-$1.317M	-$2.253M
YoY Change	167.6%	3194.04%
INVESTING ACTIVITIES
Capital Expenditures		$955.7K
YoY Change		3407.05%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities	-$52.66K	-$955.7K
YoY Change	-79.66%	3407.03%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net		$0.00
YoY Change		-100.0%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities		$161.9K
YoY Change		-97.63%
NET CHANGE
Cash From Operating Activities	-$1.317M	-$2.253M
Cash From Investing Activities	-$52.66K	-$955.7K
Cash From Financing Activities		$161.9K
Net Change In Cash	-$1.369M	-$3.047M
YoY Change	132.48%	-145.14%
FREE CASH FLOW
Cash From Operating Activities	-$1.317M	-$2.253M
Capital Expenditures		$955.7K
Free Cash Flow		-$3.208M
YoY Change		3254.73%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2022	dei	Document Type DocumentType	10-K
CY2022	dei	Document Annual Report DocumentAnnualReport	true
CY2022	dei	Document Period End Date DocumentPeriodEndDate	2022-06-30
CY2022	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--06-30
CY2022	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2022
CY2022	dei	Document Transition Report DocumentTransitionReport	false
CY2022	dei	Entity File Number EntityFileNumber	000-56218
CY2022	dei	Entity Registrant Name EntityRegistrantName	Aeluma, Inc.
CY2022	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2022	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	85-2807351
CY2022	dei	Entity Address Address Line1 EntityAddressAddressLine1	27 Castilian Drive
CY2022	dei	Entity Address City Or Town EntityAddressCityOrTown	Goleta
CY2022	dei	Entity Address State Or Province EntityAddressStateOrProvince	CA
CY2022	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	93117
CY2022	dei	City Area Code CityAreaCode	(805)
CY2022	dei	Local Phone Number LocalPhoneNumber	351-2707
CY2022	dei	Security12g Title Security12gTitle	Common Stock, $0.0001 par value
CY2022	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2022	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2022	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2022	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2022	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2022	dei	Entity Small Business EntitySmallBusiness	true
CY2022	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
CY2022	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
CY2022	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	false
CY2022	dei	Entity Shell Company EntityShellCompany	false
CY2021Q4	dei	Entity Public Float EntityPublicFloat	8748514	usd
CY2022Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	10650002	shares
CY2022	dei	Auditor Name AuditorName	Rose, Snyder & Jacobs LLP
CY2022	dei	Auditor Location AuditorLocation	Encino, California
CY2022Q2	us-gaap	Cash Cash	3740722	usd
CY2021Q2	us-gaap	Cash Cash	6787250	usd
CY2020Q4	us-gaap	Cash Cash	38302	usd
CY2022Q2	us-gaap	Deferred Costs Current DeferredCostsCurrent	662464	usd
CY2021Q2	us-gaap	Deferred Costs Current DeferredCostsCurrent	662464	usd
CY2022Q2	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	27662	usd
CY2021Q2	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	22521	usd
CY2022Q2	us-gaap	Assets Current AssetsCurrent	4430848	usd
CY2021Q2	us-gaap	Assets Current AssetsCurrent	7472235	usd
CY2020Q4	us-gaap	Assets Current AssetsCurrent	38302	usd
CY2022Q2	us-gaap	Property Plant And Equipment Other PropertyPlantAndEquipmentOther	619613	usd
CY2021Q2	us-gaap	Property Plant And Equipment Other PropertyPlantAndEquipmentOther	115888	usd
CY2020Q4	us-gaap	Property Plant And Equipment Other PropertyPlantAndEquipmentOther	115888	usd
CY2022Q2	us-gaap	Leasehold Improvements Gross LeaseholdImprovementsGross	464362	usd
CY2021Q2	us-gaap	Leasehold Improvements Gross LeaseholdImprovementsGross	12420	usd
CY2022Q2	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	96987	usd
CY2022Q2	almu	Net Fixed Assets NetFixedAssets	986988	usd
CY2021Q2	almu	Net Fixed Assets NetFixedAssets	128308	usd
CY2021Q2	us-gaap	Deferred Costs DeferredCosts	673498	usd
CY2022Q2	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	13014	usd
CY2020Q4	almu	Net Fixed Assets NetFixedAssets	115888	usd
CY2022Q2	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	12833	usd
CY2021Q2	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	14833	usd
CY2022Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	476370	usd
CY2021Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	729176	usd
CY2022Q2	us-gaap	Deferred Costs DeferredCosts	11034	usd
CY2021Q2	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	65069	usd
CY2022Q2	us-gaap	Assets Assets	5931087	usd
CY2021Q2	us-gaap	Assets Assets	9083119	usd
CY2020Q4	us-gaap	Assets Assets	154190	usd
CY2022Q2	us-gaap	Convertible Notes Payable Current ConvertibleNotesPayableCurrent	114100	usd
CY2021Q2	us-gaap	Convertible Notes Payable Current ConvertibleNotesPayableCurrent	68575	usd
CY2020Q4	us-gaap	Convertible Notes Payable Current ConvertibleNotesPayableCurrent	2886	usd
CY2022Q2	us-gaap	Accounts Payable And Other Accrued Liabilities Current AccountsPayableAndOtherAccruedLiabilitiesCurrent	101351	usd
CY2021Q2	us-gaap	Accounts Payable And Other Accrued Liabilities Current AccountsPayableAndOtherAccruedLiabilitiesCurrent	61384	usd
CY2020Q4	us-gaap	Accounts Payable And Other Accrued Liabilities Current AccountsPayableAndOtherAccruedLiabilitiesCurrent	8407	usd
CY2020Q4	us-gaap	Customer Advances Current CustomerAdvancesCurrent	16616	usd
CY2022Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	156988	usd
CY2021Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	157141	usd
CY2020Q4	us-gaap	Notes Payable Related Parties Classified Current NotesPayableRelatedPartiesClassifiedCurrent	120000	usd
CY2022Q2	us-gaap	Liabilities Current LiabilitiesCurrent	372439	usd
CY2021Q2	us-gaap	Liabilities Current LiabilitiesCurrent	287100	usd
CY2020Q4	us-gaap	Liabilities Current LiabilitiesCurrent	147909	usd
CY2022Q2	us-gaap	Finance Lease Liability FinanceLeaseLiability	458705	usd
CY2021Q2	us-gaap	Finance Lease Liability FinanceLeaseLiability	610455	usd
CY2022Q2	us-gaap	Liabilities Liabilities	831144	usd
CY2021Q2	us-gaap	Liabilities Liabilities	897555	usd
CY2020Q4	us-gaap	Liabilities Liabilities	147909	usd
CY2022Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2021Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2020Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2022Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2021Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2020Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	10000000	shares
CY2022Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2021Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2020Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2022Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	50000000	shares
CY2021Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	50000000	shares
CY2020Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	50000000	shares
CY2022Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	10650002	shares
CY2022Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	10650002	shares
CY2021Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	10535002	shares
CY2020	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	20000	usd
CY2020	us-gaap	Net Income Loss NetIncomeLoss	-13470	usd
CY2021Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	10535002	shares
CY2020Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	3247840	shares
CY2020Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	3247840	shares
CY2022Q2	us-gaap	Common Stock Value CommonStockValue	1066	usd
CY2021Q2	us-gaap	Common Stock Value CommonStockValue	1054	usd
CY2020Q4	us-gaap	Common Stock Value CommonStockValue	325	usd
CY2022Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	8781361	usd
CY2021Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	8415432	usd
CY2020Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	19675	usd
CY2022Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-3682484	usd
CY2021Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-230922	usd
CY2020Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-13719	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	5099943	usd
CY2021Q2	us-gaap	Stockholders Equity StockholdersEquity	8185564	usd
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	6281	usd
CY2022Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	5931087	usd
CY2021Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	9083119	usd
CY2020Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	154190	usd
CY2022	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1063926	usd
CY2022	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1906530	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	162533	usd
CY2020	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	11670	usd
CY2022	almu	Facility Facility	-435814	usd
	almu	Facility Facility	-91259	usd
CY2022	us-gaap	General Insurance Expense GeneralInsuranceExpense	327252	usd
	us-gaap	General Insurance Expense GeneralInsuranceExpense	2061	usd
CY2022	us-gaap	Operating Expenses OperatingExpenses	3733522	usd
	us-gaap	Operating Expenses OperatingExpenses	255853	usd
CY2020	us-gaap	Operating Expenses OperatingExpenses	11670	usd
CY2022	us-gaap	Other Income OtherIncome	279727	usd
	us-gaap	Other Income OtherIncome	90758	usd
	almu	Change In Value Of Liability ChangeInValueOfLiability	48308	usd
CY2022	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	2096	usd
	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	-3000	usd
CY2020	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	1000	usd
CY2022	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	281823	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	39450	usd
CY2020	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	1000	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-3451699	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-216403	usd
CY2020	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-12670	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	800	usd
CY2020	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	800	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-3451699	usd
	us-gaap	Net Income Loss NetIncomeLoss	-217203	usd
	us-gaap	Net Income Loss NetIncomeLoss	-217203	usd
CY2021Q2	us-gaap	Stockholders Equity StockholdersEquity	8185564	usd
CY2022	us-gaap	Proceeds From Debt Net Of Issuance Costs ProceedsFromDebtNetOfIssuanceCosts	23070	usd
CY2020	us-gaap	Net Income Loss NetIncomeLoss	-13470	usd
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.32
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.06
CY2020	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.02
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	10650002	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	3643728	shares
CY2020	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	560586	shares
CY2019Q4	us-gaap	Stockholders Equity StockholdersEquity	-249	usd
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	6281	usd
	almu	Recapitalization Recapitalization	-52924	usd
	us-gaap	Proceeds From Debt Net Of Issuance Costs ProceedsFromDebtNetOfIssuanceCosts	1059505	usd
	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	6710495	usd
	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	100000	usd
	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	258308	usd
	us-gaap	Stock Issued During Period Value Acquisitions StockIssuedDuringPeriodValueAcquisitions	1380607	usd
CY2022	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	206930	usd
CY2022	almu	Other Offering Costs OtherOfferingCosts	-45000	usd
CY2022	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	204011	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-3451699	usd
CY2022	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	137	usd
CY2022Q2	us-gaap	Stockholders Equity StockholdersEquity	5099943	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-3451699	usd
	us-gaap	Net Income Loss NetIncomeLoss	-217203	usd
CY2020	us-gaap	Net Income Loss NetIncomeLoss	-13470	usd
CY2022	us-gaap	Operating Lease Right Of Use Asset Amortization Expense OperatingLeaseRightOfUseAssetAmortizationExpense	662464	usd
CY2022	almu	Partial Refund Of Facility Lease Deposit PartialRefundOfFacilityLeaseDeposit	52055	usd
CY2022	almu	Lessor Incentive LessorIncentive	134625	usd
CY2022	us-gaap	Share Based Compensation ShareBasedCompensation	204011	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	36473	usd
	almu	Increase Decrease In Change In Lease Liability IncreaseDecreaseInChangeInLeaseLiability	-48308	usd
CY2022	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	98987	usd
CY2022	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	5141	usd
	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	22521	usd
	almu	Increase Decrease In Change In Deposits IncreaseDecreaseInChangeInDeposits	-65069	usd
CY2022	us-gaap	Increase Decrease In Other Accounts Payable IncreaseDecreaseInOtherAccountsPayable	45525	usd
	us-gaap	Increase Decrease In Other Accounts Payable IncreaseDecreaseInOtherAccountsPayable	60264	usd
CY2020	us-gaap	Increase Decrease In Other Accounts Payable IncreaseDecreaseInOtherAccountsPayable	2886	usd
CY2022	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	6382	usd
	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	91354	usd
CY2020	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	9207	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-2252791	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-68394	usd
CY2020	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-1377	usd
CY2022	almu	Purchase Of Equipment Cip PurchaseOfEquipmentCIP	503725	usd
CY2020	almu	Purchase Of Equipment Cip PurchaseOfEquipmentCIP	106228	usd
CY2022	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	451942	usd
	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	12420	usd
	almu	Purchase Of Domain Name PurchaseOfDomainName	14833	usd
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-955667	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-27253	usd
CY2020	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-106228	usd
	almu	Proceeds From Sales Of Shares To Advisor ProceedsFromSalesOfSharesToAdvisor	8171	usd
CY2020	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	20000	usd
CY2020	us-gaap	Proceeds From Advances For Construction ProceedsFromAdvancesForConstruction	125701	usd
	almu	Cash From Acquisition CashFromAcquisition	2556	usd
	almu	Proceeds From Safe Notes ProceedsFromSAFENotes	210000	usd
CY2022	us-gaap	Proceeds From Issuance Of Private Placement ProceedsFromIssuanceOfPrivatePlacement	206930	usd
	us-gaap	Proceeds From Issuance Of Private Placement ProceedsFromIssuanceOfPrivatePlacement	6760484	usd
CY2022	us-gaap	Payments For Repurchase Of Initial Public Offering PaymentsForRepurchaseOfInitialPublicOffering	45000	usd
	us-gaap	Repayments Of Other Short Term Debt RepaymentsOfOtherShortTermDebt	136616	usd
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	161930	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	6844595	usd
CY2020	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	145701	usd
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-3046528	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	6748948	usd
CY2020	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	38096	usd
CY2021Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	6787250	usd
CY2020Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	38302	usd
CY2019Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	206	usd
CY2022Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	3740722	usd
CY2021Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	6787250	usd
CY2020Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	38302	usd
	us-gaap	Net Income Loss Including Portion Attributable To Nonredeemable Noncontrolling Interest NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest	258308	usd
CY2020	us-gaap	Adjustment Of Warrants Granted For Services AdjustmentOfWarrantsGrantedForServices	800	usd
CY2020	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	9600	usd
CY2022Q2	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	1.299135853	shares
CY2022Q2	us-gaap	Capital Units Authorized CapitalUnitsAuthorized	4100000	shares
CY2021Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue		usd
CY2022	almu	Aggregate Shares AggregateShares	2500000	shares
CY2022	us-gaap	Profit Loss ProfitLoss	3451699	usd
CY2022Q2	us-gaap	Retained Earnings Appropriated RetainedEarningsAppropriated	3586435	usd
CY2020Q4	almu	Issued And Vested Shares Description IssuedAndVestedSharesDescription	On October 27th, 2020, the Company issued 1,623,920 shares of common stock to Director and CEO Jonathan Klamkin and 1,623,920 shares of common stock to Director, interim CFO and COO, Lee McCarthy for an aggregate sum of $10,000 each. The stock purchase agreement contains a repurchase option whereby unvested shares may be repurchased by the Company, at the Company’s option, within 90 days after employee termination. 324,784 shares vested on October 27, 2020 and the remaining 1,299,136 shares vest in equal amounts, monthly over the subsequent 4 years.
CY2022	us-gaap	Use Of Estimates UseOfEstimates	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; "><span style="text-decoration:underline">Use of Estimates and Assumptions</span></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; ">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. The Company bases its estimates and assumptions on current facts, historical experience and various other factors that it believes to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities. The actual results experienced by the Company may differ materially and adversely from the Company’s estimates. To the extent there are material differences between the estimates and the actual results, future results of operations will be affected.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"> </p>
	us-gaap	Interest Expense Other InterestExpenseOther	3000	usd
CY2022	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; "><span style="text-decoration:underline">Concentration of Risk</span></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; ">The Company maintains its cash in bank deposit accounts which, at times, may exceed federally insured limits. The Company has not experienced any losses in such accounts.</span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2022	almu	Vested Shares VestedShares	866090	shares
CY2022	almu	Unvested Shares UnvestedShares	757830	shares
CY2021Q2	almu	Stock Based Compensation StockBasedCompensation	36473	usd
CY2022	us-gaap	Finite Lived Intangible Assets Amortization Method FiniteLivedIntangibleAssetsAmortizationMethod	10 years
CY2021Q1	almu	Cash Agreements CashAgreements	210000	usd
CY2021Q2	us-gaap	Conversion Of Stock Shares Converted1 ConversionOfStockSharesConverted1	129154	shares
CY2021Q2	us-gaap	Debt Conversion Converted Instrument Amount1 DebtConversionConvertedInstrumentAmount1	48308	usd
CY2022Q2	us-gaap	Excess Stock Shares Authorized ExcessStockSharesAuthorized	50000000	shares
CY2022Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2022	us-gaap	Unrecognized Tax Benefits Income Tax Penalties Expense UnrecognizedTaxBenefitsIncomeTaxPenaltiesExpense	0	usd
CY2022	almu	Registration Rights Agreement Description RegistrationRightsAgreementDescription	The maximum amount of liquidated damages that may be paid by the Company shall be an amount equal to eight percent (8%) of the shares covered by the registration rights agreement. This filing covered 11,010,002 shares. The Company currently expects to satisfy all of its obligations under the Registration Agreement and does not expect to pay any damages pursuant to this agreement; therefore, no liability has been recorded.
	us-gaap	Sale Of Stock Number Of Shares Issued In Transaction SaleOfStockNumberOfSharesIssuedInTransaction	723008	shares
CY2022	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	1372435	usd
CY2022Q2	almu	Stock Based Compensation StockBasedCompensation	662464	usd
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber		shares
	us-gaap	Repayments Of Debt RepaymentsOfDebt	16616	usd
CY2020Q4	almu	Promissory Notes PromissoryNotes	60000	usd
CY2021Q4	us-gaap	Debt Instrument Interest Rate Stated Percentage DebtInstrumentInterestRateStatedPercentage	0.05	pure
CY2021	us-gaap	Debt Instrument Maturity Date DebtInstrumentMaturityDate	2021-12-31
	us-gaap	Interest Expense InterestExpense	1000	usd
CY2022Q2	us-gaap	Preferred Units Authorized PreferredUnitsAuthorized	10000000	shares
CY2022Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2022	us-gaap	Investment Company Incentive Fee To Average Net Assets InvestmentCompanyIncentiveFeeToAverageNetAssets	0.10	pure
CY2022	almu	Investors In The Offering InvestorsInTheOffering	0.03	pure
CY2022	almu	Gross Proceeds Raised GrossProceedsRaised	800000	usd
CY2022Q2	us-gaap	Excess Stock Shares Issued ExcessStockSharesIssued	50000	shares
CY2022	almu	Number Of Shares Of Common Stock NumberOfSharesOfCommonStock	0.10	pure
CY2022	us-gaap	Dividends Common Stock Stock DividendsCommonStockStock	800000	usd
CY2022	us-gaap	Debt Instrument Term DebtInstrumentTerm	P5Y
CY2022Q2	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	2
CY2021Q2	us-gaap	Deferred Sales Commission DeferredSalesCommission	725900	usd
CY2021Q2	us-gaap	Excess Stock Shares Issued ExcessStockSharesIssued	50000	shares
CY2021Q2	us-gaap	Common Stock Other Shares Outstanding CommonStockOtherSharesOutstanding	348500	shares
CY2022	us-gaap	Legal Fees LegalFees	233605	usd
CY2022Q2	us-gaap	Financing Receivable Revolving FinancingReceivableRevolving	50000	usd
CY2022	us-gaap	Loan Processing Fee LoanProcessingFee	23070	usd
CY2022	almu	Additional Paid Offering Costs AdditionalPaidOfferingCosts	45000	usd
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
CY2022	almu	Deferred Compensation Costs DeferredCompensationCosts	673498	usd
CY2022	almu	Exceptd Expenses Deferred Compensation ExceptdExpensesDeferredCompensation	662464	usd
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	723008	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	1.9
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod	31776	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue	1.9
CY2021Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	691232	shares
CY2021Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	1.9
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod	346807	shares
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue	1.9
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	344426	shares
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	1.9
CY2022	almu	Stock Based Compensation Expense Description StockBasedCompensationExpenseDescription	the Company issued an option to purchase 10,000 shares of common stock to a director at a price of $2.00 per share, expiring in 10 years, and an option to purchase 10,000 shares of common stock to an advisor at a price of $2.00 per share expiring in 5 years. These options vested over periods ranging from one month to three months.In December of 2021, the Company issued options to purchase common stock to two directors in increments of 125,000 each. The options have an exercise price of $2.00, expire in 10 years, vest 12,500 options per quarter in the first year and 9,375 per quarter for the following two years. In February of 2022, the company granted 16,750 in options to one director and 15,500 to another director at a price of $2.00 per share, for committee service. These options are subject to quarterly vesting over four quarters and expire in 10 years. On February 1, 2022, the Company entered into a consulting advisory agreement which grants 2,500 options with every patent filing. On February 4, 2022, the advisor was granted 2,500 options with an exercise price of $2.00 and an expiration date of ten years. In April of 2022, the Company issued 513,000 options to purchase common stock to employees. The options have an exercise price of $2.00 and expire in 10 years with 25% vesting after one year and the remainder scheduled to vest each quarter for three years, subject to the continued status as an employee to the Company through each vesting date. The estimated weighted average fair value of the options granted during the twelve months ended June 30, 2022 were approximately $1.50 per share.
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	1	pure
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P5Y
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0	pure
CY2022	almu	Stockbased Compensation Expenses For Options Granted StockbasedCompensationExpensesForOptionsGranted	204011	usd
CY2022	us-gaap	Deferred Compensation Arrangement With Individual Allocated Share Based Compensation Expense DeferredCompensationArrangementWithIndividualAllocatedShareBasedCompensationExpense	1018014	usd
CY2022	almu	Average Expected Recognition Period AverageExpectedRecognitionPeriod	P3Y2M12D
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Granted ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted	817750	shares
CY2022Q2	almu	Weighted Average Exercise Price Granted WeightedAverageExercisePriceGranted	2
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice	2
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber	817750	shares
CY2022Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue	2
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	83250	shares
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	2
CY2021Q2	us-gaap	Lessor Operating Lease Lease Not Yet Commenced Description LessorOperatingLeaseLeaseNotYetCommencedDescription	On April 1, 2021, the Company commenced a 5-year operating lease for a facility in Santa Barbara, California with total lease payments of $781,813.
CY2022Q2	almu	Lease Incentive LeaseIncentive	134625	usd
CY2022	almu	Lease Payments LeasePayments	767553	shares
CY2022Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	161070	usd
CY2022Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	165096	usd
CY2022Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	169224	usd
CY2022Q2	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	129324	usd
CY2022Q2	us-gaap	Operating Leases Future Minimum Payments Due OperatingLeasesFutureMinimumPaymentsDue	624714	usd
CY2022Q2	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	9021	usd
CY2022Q2	us-gaap	Operating Lease Liability OperatingLeaseLiability	615693	usd
CY2022Q2	almu	Operating Lease Less Current Portion OperatingLeaseLessCurrentPortion	156988	usd
CY2022Q2	us-gaap	Long Term Debt And Capital Lease Obligations LongTermDebtAndCapitalLeaseObligations	458705	usd
CY2022Q2	us-gaap	Lessor Operating Lease Term Of Contract LessorOperatingLeaseTermOfContract	P3Y9M
CY2022Q2	us-gaap	Lessee Operating Lease Discount Rate LesseeOperatingLeaseDiscountRate	0.0075	pure
CY2022	us-gaap	Operating Lease Cost OperatingLeaseCost	157141	usd
	us-gaap	Operating Lease Cost OperatingLeaseCost	39090	usd
CY2020	us-gaap	Operating Lease Cost OperatingLeaseCost	0	usd
CY2022	us-gaap	Variable Lease Cost VariableLeaseCost	240421	usd
	us-gaap	Variable Lease Cost VariableLeaseCost	30783	usd
CY2020	us-gaap	Variable Lease Cost VariableLeaseCost	0	usd
CY2022	us-gaap	Lessee Operating Lease Description LesseeOperatingLeaseDescription	The sub-lease provides for base monthly rent of $13,013 through May 31, 2021 and $8,400 starting June 1, 2021 plus common area operating and utility costs. The sublease was amended on February 7, 2022 to sublease a smaller portion of the property at a base rental rate of $6,930 per month effective March 1, 2022. The sublease was amended again on May 17, 2022 to sublease a smaller portion of the property at a base rental rate of $5,200 per month effective June 1, 2022.
CY2022	us-gaap	Operating Leases Rent Expense Sublease Rentals1 OperatingLeasesRentExpenseSubleaseRentals1	279727	usd
	us-gaap	Operating Leases Rent Expense Sublease Rentals1 OperatingLeasesRentExpenseSubleaseRentals1	84743	usd
CY2022	almu	Warrants To Purcahase Common Stock WarrantsToPurcahaseCommonStock	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Note 9 – Warrants to Purchase Common Stock</b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In connection with the Offering, the Company issued 360,000 warrants to purchase common stock to the Placement Agents. The warrants carry a term of 5 years and an exercise price of $2.00.</span></p>
CY2022	almu	Warrants To Purcahase Common Stock Description WarrantsToPurcahaseCommonStockDescription	In connection with the Offering, the Company issued 360,000 warrants to purchase common stock to the Placement Agents. The warrants carry a term of 5 years and an exercise price of $2.00.
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod		shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross		shares
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod		shares
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
CY2021Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber		shares
CY2021Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Nonvested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense		usd
CY2020	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense		usd
CY2020	us-gaap	General Insurance Expense GeneralInsuranceExpense		usd
CY2020	us-gaap	Other Income OtherIncome		usd
CY2022	almu	Change In Value Of Liability ChangeInValueOfLiability		usd
CY2020	almu	Change In Value Of Liability ChangeInValueOfLiability		usd
CY2022	almu	Purchase Of Domain Name PurchaseOfDomainName		usd
CY2020	almu	Purchase Of Domain Name PurchaseOfDomainName		usd
CY2022	almu	Proceeds From Sales Of Shares To Advisor ProceedsFromSalesOfSharesToAdvisor		usd
CY2020	almu	Proceeds From Sales Of Shares To Advisor ProceedsFromSalesOfSharesToAdvisor		usd
CY2022	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock		usd
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock		usd
CY2022	us-gaap	Proceeds From Advances For Construction ProceedsFromAdvancesForConstruction		usd
	us-gaap	Proceeds From Advances For Construction ProceedsFromAdvancesForConstruction		usd
	us-gaap	Payments For Repurchase Of Initial Public Offering PaymentsForRepurchaseOfInitialPublicOffering		usd
CY2022	us-gaap	Repayments Of Other Short Term Debt RepaymentsOfOtherShortTermDebt		usd
CY2020	us-gaap	Repayments Of Other Short Term Debt RepaymentsOfOtherShortTermDebt		usd
CY2022	us-gaap	Net Income Loss Including Portion Attributable To Nonredeemable Noncontrolling Interest NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest		usd
CY2020	us-gaap	Net Income Loss Including Portion Attributable To Nonredeemable Noncontrolling Interest NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest		usd
CY2022	us-gaap	Adjustment Of Warrants Granted For Services AdjustmentOfWarrantsGrantedForServices		usd
	us-gaap	Adjustment Of Warrants Granted For Services AdjustmentOfWarrantsGrantedForServices		usd
CY2022	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax		usd
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax		usd
CY2022Q2	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued		shares
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod		shares
CY2022Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue		usd
CY2022Q2	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1		usd
CY2022	dei	Amendment Flag AmendmentFlag	false
CY2022	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2022	dei	Entity Central Index Key EntityCentralIndexKey	0001828805

Files In Submission

Name	View Source	Status
0001213900-22-059543-index-headers.html	Edgar Link	pending
0001213900-22-059543-index.html	Edgar Link	pending
0001213900-22-059543.txt	Edgar Link	pending
0001213900-22-059543-xbrl.zip	Edgar Link	pending
almu-20220630.xsd	Edgar Link	pending
f10k2022ex31-1_aelumainc.htm	Edgar Link	pending
f10k2022ex31-2_aelumainc.htm	Edgar Link	pending
f10k2022ex32-1_aelumainc.htm	Edgar Link	pending
f10k2022_aelumainc.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
almu-20220630_cal.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
almu-20220630_pre.xml	Edgar Link	unprocessable
almu-20220630_lab.xml	Edgar Link	unprocessable
f10k2022_aelumainc_htm.xml	Edgar Link	completed
almu-20220630_def.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$ALMU
Aeluma, Inc. Stock $almu

2022 Q3 Form 10-K Financial Statement

#000121390022059543 Filed on September 28, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ALMU Aeluma, Inc. Stock $almu

2022 Q3 Form 10-K Financial Statement

#000121390022059543 Filed on September 28, 2022

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$ALMU
Aeluma, Inc. Stock $almu